OTCMKTS:APNHY Aspen Pharmacare (APNHY) Stock Price, News & Analysis → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free APNHY Stock Alerts $12.51 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$12.51▼$12.5150-Day Range$10.04▼$12.5152-Week Range$8.35▼$12.51Volume1 shsAverage Volume215 shsMarket Capitalization$5.58 billionP/E RatioN/ADividend Yield1.04%Price TargetN/A Stock AnalysisStock AnalysisChartDividendFinancialsHeadlinesShort InterestStock AnalysisChartDividendFinancialsHeadlinesShort Interest Get Aspen Pharmacare alerts: Email Address Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About Aspen Pharmacare Stock (OTCMKTS:APNHY)Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.Read More APNHY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APNHY Stock News HeadlinesApril 6, 2024 | msn.comAspen Completes Strategic Transactions with Sandoz to Enhance Global PresenceMarch 19, 2024 | finance.yahoo.comInvestors in Aspen Pharmacare Holdings (JSE:APN) have seen impressive returns of 144% over the past five yearsMay 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.March 7, 2024 | seekingalpha.comAspen Pharmacare Holdings Limited (APNHF) Q2 2024 Earnings Call TranscriptMarch 4, 2024 | msn.comAspen Pharmacare expects FY mid-single digit earnings growthFebruary 16, 2024 | wsj.comAspen Pharmacare Holdings Ltd. ADRJanuary 28, 2024 | investing.comAspen Pharmacare Holdings Ltd (APNJ)December 28, 2023 | finance.yahoo.comInstitutional investors are Aspen Pharmacare Holdings Limited's (JSE:APN) biggest bettors and were rewarded after last week's R3.4b market cap gainMay 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.December 10, 2023 | seekingalpha.comWeek In Review: Abbisko Sells China Rights For CSF-1R Inhibitor To Merck In $605M DealDecember 1, 2023 | finance.yahoo.comShareholders May Not Be So Generous With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation And Here's WhyNovember 1, 2023 | finance.yahoo.comAspen Pharmacare Holdings Limited (JSE:APN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?October 9, 2023 | finance.yahoo.comThose who invested in Aspen Pharmacare Holdings (JSE:APN) three years ago are up 56%September 21, 2023 | finance.yahoo.comAspiring for Aspen Pharmacare Holdings Ltd's Dividend: A Comprehensive AnalysisSeptember 20, 2023 | msn.comNovo Nordisk and Aspen Pharmacare in deal to produce 16 million vials of insulinSeptember 2, 2023 | finance.yahoo.comAspen Pharmacare Holdings Full Year 2023 Earnings: EPS Misses ExpectationsAugust 30, 2023 | msn.comAspen Pharmacare Holdings GAAP EPS of R$11.76, revenue of R$40.71BAugust 30, 2023 | finance.yahoo.comUPDATE 1-South African drugmaker Aspen posts 4% drop in annual profitAugust 2, 2023 | msn.comAspen Pharmacare gets Viagra as it acquires new brands to broaden its Latin America marketJuly 7, 2023 | finance.yahoo.comOwning 42% shares,institutional owners seem interested in Aspen Pharmacare Holdings Limited (JSE:APN),June 6, 2023 | bizjournals.comAspen Mountain mansion listed for $100M sells for just $65M (Photos)May 25, 2023 | finance.yahoo.comIs Aspen Pharmacare Holdings Limited's (JSE:APN) Recent Stock Performance Influenced By Its Fundamentals In Any Way?May 24, 2023 | usnews.comAspen High SchoolMay 18, 2023 | cnn.comAfrica may need its own central medicines agency, says Aspen Pharmacare CEOMay 11, 2023 | travel.usnews.comGetting Around AspenApril 28, 2023 | finance.yahoo.comAspen Pharmacare Holdings' (JSE:APN) investors will be pleased with their notable 63% return over the last three yearsMarch 4, 2023 | seekingalpha.comAspen Pharmacare Holdings Limited 2023 Q2 - Results - Earnings Call PresentationSee More Headlines Receive APNHY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aspen Pharmacare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/07/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:APNHY Previous SymbolNASDAQ:APNHY CUSIPN/A CIK1454177 Webwww.aspenpharma.com Phone(731) 580-8600Fax27-11-239-6144Employees9,161Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$2.30 billion Price / Sales2.43 Cash Flow$1.07 per share Price / Cash Flow11.70 Book Value$10.90 per share Price / Book1.15Miscellaneous Outstanding Shares446,250,000Free FloatN/AMarket Cap$5.58 billion OptionableNot Optionable Beta1.19 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Stephen Bradley Saad BCom (Age 60)CA(SA), Group CEO & Executive Director Comp: $1MMr. Sean M. Capazorio (Age 57)Group CFO & Executive Director Comp: $546.46kMs. Lorraine Hill (Age 60)Group Chief Operations Officer & Responsible Pharmacist Comp: $588.92kMr. Michael Guy Attridge B.Com. (Age 63)CA(SA), Group Chief Advisor Comp: $443.03kMr. Reginald Haman Grad. Dip. (Age 49)MBA, ND, NHD, PGDBA, Group Chief Corporate Services Officer & Executive Director Comp: $412.23kMs. Zizipho Mmango (Age 39)Group Chief Strategic Development Officer Comp: $412.18kSibongakonke NkosiInvestor Relations ManagerMr. Trevor Julian Ziman (Age 52)Regional Chief Executive Officer of Asia Pacific Mr. Samer Kassem (Age 49)Chief Executive Officer of Aspen Global Incorporated Ms. Raeesa KhanGroup Company SecretaryMore ExecutivesKey CompetitorsHikma PharmaceuticalsOTCMKTS:HKMPFSino BiopharmaceuticalOTCMKTS:SBMFFZealand Pharma A/SOTCMKTS:ZLDPFOrion OyjOTCMKTS:ORINYAurora CannabisOTCMKTS:ACBFFView All Competitors APNHY Stock Analysis - Frequently Asked Questions How have APNHY shares performed in 2024? Aspen Pharmacare's stock was trading at $10.97 at the beginning of the year. Since then, APNHY stock has increased by 14.0% and is now trading at $12.51. View the best growth stocks for 2024 here. Are investors shorting Aspen Pharmacare? Aspen Pharmacare saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 1,200 shares, a decline of 64.7% from the March 31st total of 3,400 shares. Based on an average trading volume of 200 shares, the short-interest ratio is presently 6.0 days. View Aspen Pharmacare's Short Interest. How often does Aspen Pharmacare pay dividends? What is the dividend yield for Aspen Pharmacare? Aspen Pharmacare declared a dividend on Thursday, September 21st. Investors of record on Friday, September 22nd will be given a dividend of $0.1297 per share on Wednesday, October 11th. The ex-dividend date is Thursday, September 21st. Read our dividend analysis for APNHY. Is Aspen Pharmacare a good dividend stock? Aspen Pharmacare (OTCMKTS:APNHY) pays an annual dividend of $0.13 per share and currently has a dividend yield of 1.01%. Read our dividend analysis for APNHY. How do I buy shares of Aspen Pharmacare? Shares of APNHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:APNHY) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspen Pharmacare Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
